At Lumina Life Sciences, our mission is to support advancement of innovative life-science technologies by partnering closely with Boards and Management teams in biopharma companies and Investment funds.
We have decades of experience in Global markets across In-and Out-Licensing and Business Development, M&A, Commercialisation Strategy and New Product Planning, Portfolio and therapy area strategy and Market access, and organizational builds.
Our expertise extends across small molecules, biologics, medical devices and digital health. Our team members have direct, on-the-ground experience in the United States, Europe and Asia.
Develop and evolve your portfolio and corporate strategy to maximise value for investors and potential partners
Generate and leveage insights to refine the valuation of the asset and company ; Valuation modeling with defensible assumptions grounded in referenceable data
Develop a clear equity story and marketing materials tailored towards investor and and strategic partners
Working with you to build options for partnering, deal structures, processes and build outreach plan.
Directly support execution of the outreach plan including valuation defence, term sheet negotiation and deal closing.
Strong scientific background with experience extendi across psychiatry, neurology, immunology, rare diseases, nephrology, oncology, cardiology and metabolic diseases, ophthalmology, and others.
We work with several of the top VC funds in the US and in Europe as well as biopharma companies. Our approach is to collaborate with you to find a model that works for your needs